Mechanistic exploration of AhR-mediated host protection against Streptococcus pneumoniae infection

International Immunopharmacology

Volumn 13, Issue 4, 2012, Pages 490-498

  Wang, Tao ^a   Wyrick, Katherine L ^a   Pecka, Melanie R ^a   Wills, Tamara B ^a   Vorderstrasse, Beth A ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Aryl hydrocarbon receptor; Host protection; iNKT cells; Natural antibodies; Streptococcus pneumoniae; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CELL POPULATION; EPITHELIUM CELL; IMMUNE RESPONSE; INNATE IMMUNITY; LUNG INFECTION; LUNG PARENCHYMA; MACROPHAGE; MALE; MORTALITY; MOUSE; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL;

ANIMALS; ANTI-INFECTIVE AGENTS; CELL GROWTH PROCESSES; CELLULAR MICROENVIRONMENT; HOST-PATHOGEN INTERACTIONS; LUNG; MICE; MICE, INBRED C57BL; RECEPTORS, ARYL HYDROCARBON; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; TETRACHLORODIBENZODIOXIN;

EID: 84862317958     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.05.008     Document Type: Article

References (48)

1. T.J. Mitchell The pathogenesis of streptococcal infections: from tooth decay to meningitis Nat Rev Microbiol 1 2003 219 230
2. A. Kadioglu, and P.W. Andrew The innate immune response to pneumococcal lung infection: the untold story Trends Immunol 25 2004 143 149
3. A.M. Minino, M.P. Heron, S.L. Murphy, and K.D. Kochanek Deaths: final data for 2004 Natl Vital Stat Rep 55 2007 1 119
4. J. Quale, D. Landman, J. Ravishankar, C. Flores, and S. Bratu Streptococcus pneumoniae, Brooklyn, New York: fluoroquinolone resistance at our doorstep Emerg Infect Dis 8 2002 594 597
5. B.A. Vorderstrasse, and B.P. Lawrence Protection against lethal challenge with Streptococcus pneumoniae is conferred by aryl hydrocarbon receptor activation but is not associated with an enhanced inflammatory response Infect Immun 74 2006 5679 5686
6. L.P. Nguyen, and C.A. Bradfield The search for endogenous activators of the aryl hydrocarbon receptor Chem Res Toxicol 21 2008 102 116
7. J.L. Marlowe, and A. Puga Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis J Cell Biochem 96 2005 1174 1184
8. K.W. Bock, and C. Kohle Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions Biochem Pharmacol 72 2006 393 404
9. A. Schecter, L. Birnbaum, J.J. Ryan, and J.D. Constable Dioxins: an overview Environ Res 101 2006 419 428
10. B.A. Vorderstrasse, A.A. Bohn, and B.P. Lawrence Examining the relationship between impaired host resistance and altered immune function in mice treated with TCDD Toxicology 188 2003 15 28
11. N.I. Kerkvliet Immunotoxicology of dioxins and related chemicals A. Schecter, Dioxins and health 1994 Plenum Press New York 199 225
12. J.Y. Choi, J.A. Oughton, and N.I. Kerkvliet Functional alterations in CD11b(+)Gr-1(+) cells in mice injected with allogeneic tumor cells and treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin Int Immunopharmacol 3 2003 553 570
13. A.B. Moos, L. Baecher-Steppan, and N.I. Kerkvliet Acute inflammatory response to sheep red blood cells in mice treated with 2,3,7,8- tetrachlorodibenzo-p-dioxin: the role of proinflammatory cytokines, IL-1 and TNF Toxicol Appl Pharmacol 127 1994 331 335
14. S. Teske, A.A. Bohn, J.F. Regal, J.J. Neumiller, and B.P. Lawrence Activation of the aryl hydrocarbon receptor increases pulmonary neutrophilia and diminishes host resistance to influenza A virus Am J Physiol Lung Cell Mol Physiol 289 2005 L111 L124
15. H. Neff-LaFord, S. Teske, T.P. Bushnell, and B.P. Lawrence Aryl hydrocarbon receptor activation during influenza virus infection unveils a novel pathway of IFN-gamma production by phagocytic cells J Immunol 179 2007 247 255
16. F. Fan, B. Yan, G. Wood, M. Viluksela, and K.K. Rozman Cytokines (IL-1 beta and TNF alpha) in relation to biochemical and immunological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats Toxicology 116 1997 9 16
17. H. Yin, Y. Li, and T.R. Sutter Dioxin-enhanced expression of interleukin-1 beta in human epidermal keratinocytes: potential role in the modulation of immune and inflammatory responses Exp Clin Immunogenet 11 1994 128 135
18. R.W. Luebke, C.B. Copeland, L.R. Bishop, M.J. Daniels, and M.I. Gilmour Mortality in dioxin-exposed mice infected with influenza: mitochondrial toxicity (Reye's-like Syndrome) versus enhanced inflammation as the mode of action Toxicol Sci 69 2002 109 116
19. S. Hammerschmidt Adherence molecules of pathogenic pneumococci Curr Opin Microbiol 9 2006 12 20
20. D.R. Cundell, N.P. Gerard, C. Gerard, I. Idanpaan-Heikkila, and E.I. Tuomanen Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor Nature 377 1995 435 438
21. A.R. Kerr, X.Q. Wei, P.W. Andrew, and T.J. Mitchell Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae Microb Pathog 36 2004 303 310
22. L.J. Kobrynski, A.O. Sousa, A.J. Nahmias, and F.K. Lee Cutting edge: antibody production to pneumococcal polysaccharides requires CD1 molecules and CD8 + T cells J Immunol 174 2005 1787 1790
23. M. Brigl, R.V. Tatituri, G.F. Watts, V. Bhowruth, E.A. Leadbetter, and N. Barton Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection J Exp Med 208 2011 1163 1177
24. K. Kawakami, N. Yamamoto, Y. Kinjo, K. Miyagi, C. Nakasone, and K. Uezu Critical role of Valpha14 + natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection Eur J Immunol 33 2003 3322 3330
25. J.S. Brown, T. Hussell, S.M. Gilliland, D.W. Holden, J.C. Paton, and M.R. Ehrenstein The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice Proc Natl Acad Sci U S A 99 2002 16969 16974
26. J. Casal, and D. Tarrago Immunity to Streptococcus pneumoniae: factors affecting production and efficacy Curr Opin Infect Dis 16 2003 219 224
27. C. Mold, B. Rodic-Polic, and T.W. Du Clos Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors J Immunol 168 2002 6375 6381
28. J.R. Wright Pulmonary surfactant: a front line of lung host defense J Clin Invest 111 2003 1453 1455
29. P.K. Singh, H.P. Jia, K. Wiles, J. Hesselberth, L. Liu, and B.A. Conway Production of beta-defensins by human airway epithelia Proc Natl Acad Sci U S A 95 1998 14961 14966
30. Q. Dong, and J.R. Wright Expression of C-reactive protein by alveolar macrophages J Immunol 156 1996 4815 4820
31. G.B. Jin, A.J. Moore, J.L. Head, J.J. Neumiller, and B.P. Lawrence Aryl hydrocarbon receptor activation reduces dendritic cell function during influenza virus infection Toxicol Sci 116 2010 514 522
32. K.M. Haas, J.C. Poe, D.A. Steeber, and T.F. Tedder B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae Immunity 23 2005 7 18
33. S. Shimada, M. Kawaguchi-Miyashita, A. Kushiro, T. Sato, M. Nanno, and T. Sako Generation of polymeric immunoglobulin receptor-deficient mouse with marked reduction of secretory IgA J Immunol 163 1999 5367 5373
34. G. Rajam, D. Jackson, T. Pilishvili, C.G. Whitney, R.R. Facklam, and G.M. Carlone An in vitro model to assess pneumococcal adherence to nasopharyngeal cells under competition conditions J Microbiol Methods 70 2007 219 226
35. O. Dohr, R. Sinning, C. Vogel, P. Munzel, and J. Abel Effect of transforming growth factor-beta1 on expression of aryl hydrocarbon receptor and genes of Ah gene battery: clues for independent down-regulation in A549 cells Mol Pharmacol 51 1997 703 710
36. V. Agarwal, and S. Hammerschmidt Cdc42 and the phosphatidylinositol 3-kinase-Akt pathway are essential for PspC-mediated internalization of pneumococci by respiratory epithelial cells J Biol Chem 284 2009 19427 19436
37. J.M. Anderton, G. Rajam, S. Romero-Steiner, S. Summer, A.P. Kowalczyk, and G.M. Carlone E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of Streptococcus pneumoniae Microb Pathog 42 2007 225 236
38. J.M. Gould, and J.N. Weiser The inhibitory effect of C-reactive protein on bacterial phosphorylcholine platelet-activating factor receptor-mediated adherence is blocked by surfactant J Infect Dis 186 2002 361 371
39. T.K. Warren, K.A. Mitchell, and B.P. Lawrence Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated immune responses to influenza A virus without affecting cytolytic activity in the lung Toxicol Sci 56 2000 114 123
40. N.I. Kerkvliet, and J.A. Oughton Acute inflammatory response to sheep red blood cell challenge in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): phenotypic and functional analysis of peritoneal exudate cells Toxicol Appl Pharmacol 119 1993 248 257
41. D.A. Kaminski, and J. Stavnezer Enhanced IgA class switching in marginal zone and B1 B cells relative to follicular/B2 B cells J Immunol 177 2006 6025 6029
42. K.M. Ansel, R.B. Harris, and J.G. Cyster CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity Immunity 16 2002 67 76
43. H. Kinoshita, J. Abe, K. Akadegawa, H. Yurino, T. Uchida, and S. Ikeda Breakdown of mucosal immunity in gut by 2,3,7,8-tetraclorodibenzo-p-dioxin (TCDD) Environ Health Prev Med 11 2006 256 263
44. R.A. Moran, C.W. Lee, J.M. Fujimoto, and N.J. Calvanico Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on IgA serum and bile levels in rats Immunopharmacology 12 1986 245 250
45. S. Ishikawa Children's immunology, what can we learn from animal studies (3): impaired mucosal immunity in the gut by 2,3,7,8-tetraclorodibenzo-p-dioxin (TCDD): a possible role for allergic sensitization J Toxicol Sci 34 Suppl. 2 2009 SP349 SP361
46. M. Kronenberg, and Y. Kinjo Innate-like recognition of microbes by invariant natural killer T cells Curr Opin Immunol 21 2009 391 396
47. L. Moreira-Teixeira, M. Resende, M. Coffre, O. Devergne, J.P. Herbeuval, and O. Hermine Proinflammatory environment dictates the IL-17-producing capacity of human invariant NKT cells J Immunol 186 2011 5758 5765
48. Y. Lai, and R.L. Gallo AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense Trends Immunol 30 2009 131 141